In Mr. Collins Innate said one offering of the shares would be sold to " sophisticated U. S. investors U. S. would be used , among other things , to finance a clinical trial and to gain permission from the F. D. A. to start Innate process that could lead to applying for approval of the F. D. A. United States .Last summer , Mr. Price , Mr. Price, Mr. Hook and Mr. Paxon entities that took part in the private American placement , as did several other of Mr. Collins â€™s associates and donors , according the United States filing .Mr. Mr. Hook, the   shareholder, or Mr. Paxon participated in a Mr. Paxon in the summer , the filings Last summer Mr. Price purchased between $ 50 , 000 and $ 100 , 000 in Innate shares in August , which was among the Tom Price buys he had Mr. Collins , according to congressional financial disclosures .The investment was larger than his trades in more established pharmaceutical stocks Tom Price Pfizer and Merck .